StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Monthly Share Repurchases by Month

Monthly Share Repurchases — Remaining share repurchase authorization at month-end ($M) ($M)

Vertex Pharmaceuticals Monthly Share Repurchases: $2,582M in Jun 2026, down 43.5% from a year earlier.

Latest, Jun 2026
2,582
Period ended Jun 28, 2026
Change on a year earlier
-43.5%
4,570 in Jun 2025
History
71 months
Since Jan 2018
Sources
26
Documents cited below

Where the Jun 2026 figure comes from

“|| June 1, 2026 to June 30 , 2026 | 292,000 | $ 452.37 | 292,000 | $ 2,582,008,580”

Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗

Reported in Form 10-Q Part II Item 2(c) & Form 10-K Item 5.

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMonthly Share Repurchases — Remaining share repurchase authorization at month-end ($M) ($M)Year on yearSource
Jun 2026Jun 28, 20262,582-43.5%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
May 2026May 28, 20262,714-42.3%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Apr 2026Apr 28, 20262,873+233.5%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Mar 2026Mar 28, 20263,037+214.9%Form 10-Q (vrtx-20260331.htm, filed 2026-05-05) ↗
Feb 2026Feb 28, 20263,163+199.2%Form 10-Q (vrtx-20260331.htm, filed 2026-05-05) ↗
Jan 2026Jan 28, 20263,263+181.9%Form 10-Q (vrtx-20260331.htm, filed 2026-05-05) ↗
Oct 2025Oct 28, 20253,382+98.9%Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
Sep 2025Sep 28, 20253,487+92.8%Form 10-Q (vrtx-20250930.htm, filed 2025-11-04) ↗
Aug 2025Aug 28, 20253,974+108.8%Form 10-Q (vrtx-20250930.htm, filed 2025-11-04) ↗
Jul 2025Jul 28, 20254,450+121.5%Form 10-Q (vrtx-20250930.htm, filed 2025-11-04) ↗
Jun 2025Jun 28, 20254,570+115.9%Form 10-Q (vrtx-20250630.htm, filed 2025-08-05) ↗
May 2025May 28, 20254,707+113.3%Form 10-Q (vrtx-20250630.htm, filed 2025-08-05) ↗
Apr 2025Apr 28, 2025862-62.7%Form 10-Q (vrtx-20250630.htm, filed 2025-08-05) ↗
Mar 2025Mar 28, 2025964-60.3%Form 10-Q (vrtx-20250331.htm, filed 2025-05-06) ↗
Feb 2025Feb 28, 20251,057-58.2%Form 10-Q (vrtx-20250331.htm, filed 2025-05-06) ↗
Jan 2025Jan 28, 20251,158-55.0%Form 10-Q (vrtx-20250331.htm, filed 2025-05-06) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Monthly Share Repurchases ($M), monthly Jan 2018–Jun 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/monthly-buyback-rem-auth

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.